YSTH-2 (Y`s Therapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameYSTH-2 (Y`s Therapeutics)
Drug Alias NameAnthy2YSTH2-O-ASYSTH2-T-AD
ClassificationSmall molecules
Mechanisms of ActionLymphocyte migration inhibitorsIL-6 receptor antagonistsCytokine synthesis inhibitors +[4] 
TargetsIL-6 receptor
Therapy Area/IndicationsDermatitis, AtopicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesY'S Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesY'S Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicAsthma

Other Information

ATC CodeN/A
Related LinksN/A